COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC

Canonical company identity and public leadership record.

NASDAQ: COLLUS

  • Source reported. 18 claims from 2 sources.
  • Not claimed by the company.
  • Eval: not assessed.
Board
5 directorsAlpha calculation. Published seats
Evidence
2 sources18 published claims
Last reviewed
Freshness: current
Open conflicts
0None open
Alpha EvalNot assessed. No Eval is published for this company.

Leadership

5 claims
Leadership
PersonRoleSinceStatusEvidence
Colleen TupperExecutive Vice President and Chief Financial OfficerNot capturedUnknownSource reportedE2

Stated in the record as Colleen Tupper: Executive Vice President and Chief Financial Officer

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:14

Report an error
David DieterExecutive Vice President, General Counsel and Corporate SecretaryNot capturedUnknownSource reportedE2

Stated in the record as David Dieter: Executive Vice President, General Counsel and Corporate Secretary

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:15

Report an error
Scott DreyerExecutive Vice President and Chief Commercial OfficerNot capturedUnknownSource reportedE2

Stated in the record as Scott Dreyer: Executive Vice President and Chief Commercial Officer

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:16

Report an error
Thomas SmithExecutive Vice President and Chief Medical OfficerNot capturedUnknownSource reportedE2

Stated in the record as Thomas Smith: Executive Vice President and Chief Medical Officer

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:17

Report an error
Vikram KarnaniPresident and Chief Executive OfficerNot capturedUnknownSource reportedE2

Stated in the record as Vikram Karnani: President and Chief Executive Officer

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:18

Report an error

Board

9 claims
Board of directors
DirectorStatusSinceCommitteesEvidence
Compliance Mr. BohlinIndependence not publishedNone publishedSource reportedE3

Stated in the record as Compliance Mr. Bohlin: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:7

Report an error
Garen BohlinIndependence not publishedNone publishedSource reportedE3

Stated in the record as Garen Bohlin: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:8

Report an error
John FreundIndependence not publishedNone publishedSource reportedE3

Stated in the record as John Freund: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:9

Report an error
Nancy LurkerIndependence not publishedNone publishedSource reportedE3

Stated in the record as Nancy Lurker: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:11

Report an error
Rita Balice-GordonIndependence not publishedNone publishedSource reportedE3

Stated in the record as Rita Balice-Gordon: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:12

Report an error
Carlos PayaIndependentNot publishedNone publishedSource reportedE2

Stated in the record as Carlos Paya: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:6

Report an error
Gino SantiniIndependent; ChairNot publishedNone publishedSource reportedE2

Stated in the record as Gino Santini: Chairman of the Board

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:5

Report an error
Michael DonovanIndependentNot publishedNone publishedSource reportedE2

Stated in the record as Michael Donovan: Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:10

Report an error
Vikram KarnaniNot independentNot publishedChief Executive Officer and DirectorSource reportedE2

Stated in the record as Vikram Karnani: President, Chief Executive Officer and Director

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:13

Report an error

Authority

1 claim
Authority to act
FactStated valueEvidence
Principal executive officerVikram Karnani, President and Chief Executive OfficerSource reportedE2Same claim as above

Stated in the record as Vikram Karnani: President and Chief Executive Officer

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:leadership_role:18

Report an error

Not in the public record: who can authorize an agent; ai agents registered by the company; delegations published.

Financial context

1 claim
Financials and market context
FactStated valueEvidence
Security listingCOLL (NASDAQ)Source reportedE1

Stated in the record as COLL (NASDAQ)

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:security_listing:19

Report an error

Other published claims

3 claims
Other published claims
FactStated valueEvidence
Legal nameCOLLEGIUM PHARMACEUTICAL, INCSource reportedE1

Stated in the record as COLLEGIUM PHARMACEUTICAL, INC

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:legal_name:1

Report an error
Entity statusPublic listing publishedSource reportedE1

Stated in the record as Public listing published

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:entity_status:3

Report an error
Published factUSSource reportedE1

Stated in the record as US

Claim ID alpha:claim:company:a85a1bf4-78cf-42cf-a474-21077fc6944c:published_fact:4

Report an error

Evidence

3 evidence records
Evidence ledger
RefSourceAuthoritySource dateRetrievedRightsCited by
E1Alpha canonical company public projectionCanonical identityOpen webNot recordedRights not recorded, link only4 claims
E2SEC DEF 14A 0001628280-26-024063SEC def 14aAuthoritative, regulatory filingRights not recorded, link only9 claims
E3DEF 14A coll-20260407.htmSEC proxyAuthoritative, regulatory filingRights not recorded, link only5 claims

No evidence record is pinned or signed yet.

Not yet in this record

These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.

  • Committees
  • Control and voting
  • Governance
  • Risk
  • AI oversight
  • Compensation

Index memberships

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Coverage states the record reports (12)
Corporate structure
Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
Ownership
Not reviewed. Ownership and voting power determine who can influence the board.
Financials
Not reviewed. Governance-relevant financial context frames capital and audit decisions.
Compensation
Not reviewed. Pay design shows how incentives are governed.
Governance
Not reviewed. Governing documents and provisions set the rules of the enterprise.
Shareholder governance
Not reviewed. Meeting and vote records show shareholder dissent and support.
Audit
Not reviewed. Auditor, controls and restatements show assurance over reporting.
Legal
Not reviewed. Material legal and regulatory matters show enforcement exposure.
Risk
Not reviewed. Risk ownership links the board, committees, executives and controls.
Cyber
Not reviewed. Cyber and data governance is a disclosed oversight domain.
AI governance
Not reviewed. AI oversight is a differentiated Alpha governance domain.
Markets external
Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

History

Version public-1

Published .

  1. Director appointed. Nancy Lurker seat on COLLEGIUM PHARMACEUTICAL, INC, effective 2025.Effective . Recorded .
  2. Director appointed. Rita Balice-Gordon seat on COLLEGIUM PHARMACEUTICAL, INC, effective 2020.Effective . Recorded .
  3. Director appointed. Compliance Mr. Bohlin seat on COLLEGIUM PHARMACEUTICAL, INC, effective 2015.Effective . Recorded .
  4. Director appointed. Garen Bohlin seat on COLLEGIUM PHARMACEUTICAL, INC, effective 2015.Effective . Recorded .
  5. Director appointed. John Freund seat on COLLEGIUM PHARMACEUTICAL, INC, effective 2014.Effective . Recorded .

About this record

Alpha ID
alpha:company:a85a1bf4-78cf-42cf-a474-21077fc6944c
Version
public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
Identity
Not claimed
Evidence
Source reported
Evaluation
Not assessed
Monitoring
Not monitored yet
Authority
Not published
Freshness
Current
Integrity
Not signed yet
Basis
Published company record built from public sources
Never published
Private company data: deployments, authority grants, TrustChecks, receipts, telemetry

The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.